Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolio

The investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based therapies, the former said in a release

from Stocks-Markets-Economic Times https://ift.tt/uQy7wp9
via IFTTT